Biochem Pharma (BCHE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Richard Haugland who wrote (459)	10/5/1998 7:22:00 PM
From: Richard Haugland	Read Replies (1) of 783

Back to BCHE: Big meeting October 6 on lamivudine. Rumor on Yahoo Board is approval coming and stock trading will halt in the morning but who knows. Sure could use a winner after today. From www.fda.gov ANTIVIRAL DRUGS ADVISORY COMMITTEE DATE AND TIME: Oct. 6, 8:30 a.m. LOCATION: Holiday Inn -- Silver Spring, Kennedy Grand Ballroom, 8777 Georgia Ave., Silver Spring, MD. CONTACT: Rhonda W. Stover or John B. Schupp, Center for Drug Evaluation and Research, 301-827-7001. The committee will discuss two new drug applications for lamivudine (Epivir HBV, Glaxo Wellcome, Inc.) for the treatment of chronic hepatitis B (tablets and oral solution).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next